865 related articles for article (PubMed ID: 3668980)
1. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
Wigley FM; Malamet R; Wise RA
J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980
[TBL] [Abstract][Full Text] [Related]
2. Digital pressure and flow measurement upon local cooling in Raynaud's disease. Effect of naftidrofuryl.
Bounameaux HM; Hellemans H; Verhaege R
Int Angiol; 1986; 5(1):39-44. PubMed ID: 3734514
[TBL] [Abstract][Full Text] [Related]
3. Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders.
Maricq HR; Weinrich MC; Valter I; Palesch YY; Maricq JG
J Rheumatol; 1996 Dec; 23(12):2068-78. PubMed ID: 8970043
[TBL] [Abstract][Full Text] [Related]
4. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP
J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
[TBL] [Abstract][Full Text] [Related]
5. [Hemodynamic response of the digital artery to heat and cold in normal subjects, in systemic scleroderma and in Raynaud's disease].
Vayssairat M; Mathieu JF; Housset E
J Mal Vasc; 1984; 9(1):7-10. PubMed ID: 6707534
[TBL] [Abstract][Full Text] [Related]
6. Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker.
Rupp PA; Mellinger S; Kohler J; Dorsey JK; Furst DE
J Rheumatol; 1987 Aug; 14(4):745-50. PubMed ID: 3312603
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Raynaud's phenomenon with captopril.
Tosi S; Marchesoni A; Messina K; Bellintani C; Sironi G; Faravelli C
Drugs Exp Clin Res; 1987; 13(1):37-42. PubMed ID: 3297593
[TBL] [Abstract][Full Text] [Related]
8. Use of biofeedback training in treatment of Raynaud's disease and phenomenon.
Yocum DE; Hodes R; Sundstrom WR; Cleeland CS
J Rheumatol; 1985 Feb; 12(1):90-3. PubMed ID: 3981523
[TBL] [Abstract][Full Text] [Related]
9. [Action of nifedipine on the post-ischemic cold hyperemia reaction in Raynaud's phenomenon].
Vayssairat M; Blaison N; Baudot N; Evenou P; Gilard M; Mathieu JF
J Mal Vasc; 1989; 14(4):299-302. PubMed ID: 2584886
[TBL] [Abstract][Full Text] [Related]
10. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
[TBL] [Abstract][Full Text] [Related]
11. [Finger plethysmography for studying the blood rheological and hemodynamic components of an acrosyndrome].
de Faucal P; Planchon B; Boudard D; Peltier P; Barrier J; Grolleau JY
J Mal Vasc; 1986; 11(4):356-61. PubMed ID: 3805897
[TBL] [Abstract][Full Text] [Related]
12. Acute effects of nifedipine on digital blood flow in human subjects with Raynaud's phenomenon: a double blind placebo controlled trial.
Wise RA; Malamet R; Wigley FM
J Rheumatol; 1987 Apr; 14(2):278-83. PubMed ID: 3298649
[TBL] [Abstract][Full Text] [Related]
13. Acute effect of topical minoxidil on digital blood flow in patients with Raynaud's phenomenon.
Whitmore SE; Wigley FM; Wise RA
J Rheumatol; 1995 Jan; 22(1):50-4. PubMed ID: 7699682
[TBL] [Abstract][Full Text] [Related]
14. Digital pressure responses to cooling in patients with suspected early vs definite scleroderma (systemic sclerosis) vs primary Raynaud's phenomenon.
Maricq HR; Diat F; Weinrich MC; Maricq JG
J Rheumatol; 1994 Aug; 21(8):1472-6. PubMed ID: 7983649
[TBL] [Abstract][Full Text] [Related]
15. Raynaud's phenomenon in systemic lupus erythematosus.
Lavras Costallat LT; Valente Coimbra AM
Rev Rhum Engl Ed; 1995 May; 62(5):349-53. PubMed ID: 7655867
[TBL] [Abstract][Full Text] [Related]
16. Nifedipine in Raynaud's phenomenon: relationship between immediate, short term and longterm effects.
Kallenberg CG; Wouda AA; Kuitert JJ; Tijssen J; Wesseling H
J Rheumatol; 1987 Apr; 14(2):284-90. PubMed ID: 3598997
[TBL] [Abstract][Full Text] [Related]
17. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
Lukác J; Rovenský J; Tauchmannová H; Zitnan D
Drugs Exp Clin Res; 1985; 11(9):659-63. PubMed ID: 3916837
[TBL] [Abstract][Full Text] [Related]
18. [Thermographic assessment of Raynaud's phenomenon in childhood mixed connective tissue disease].
Yokota S; Kuriyama T; Takahashi Y; Mori M; Shike H; Ibe M; Mitsuda T; Aihara Y
Ryumachi; 1994 Dec; 34(6):955-60. PubMed ID: 7863385
[TBL] [Abstract][Full Text] [Related]
19. Plethysmographic cold test for diagnosis and evaluation of the severity of Raynaud's phenomenon. Validation of the method by factorial analysis of correspondences in 541 patients.
Pistorius MA; Planchon B; de Faucal P
Int Angiol; 1994 Mar; 13(1):10-4. PubMed ID: 8077791
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
Fries R; Shariat K; von Wilmowsky H; Böhm M
Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
